The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Brain metabolic dysfunction at the core of Alzheimer's disease
Open accessAbstract
Growing evidence supports the concept that Alzheimer’s disease (AD) is fundamentally a metabolic disease with molecular and biochemical features that correspond with diabetes mellitus and other peripheral insulin resistance disorders. Brain insulin/IGF resistance and its consequences can readily account for most of the structural and functional abnormalities in AD. However, disease pathogenesis is complicated by the fact that AD can occur as a separate disease process, or arise in association with systemic insulin resistance diseases, including diabetes, obesity, and non-alcoholic fatty liver disease. Whether primary or secondary in origin, brain insulin/IGF resistance initiates a cascade of neurodegeneration that is propagated by metabolic dysfunction, increased oxidative and ER stress, neuro-inflammation, impaired cell survival, and dysregulated lipid metabolism. These injurious processes compromise neuronal and glial functions, reduce neurotransmitter homeostasis, and cause toxic oligomeric pTau and (amyloid beta peptide of amyloid beta precursor protein) AβPP-Aβ fibrils and insoluble aggregates (neurofibrillary tangles and plaques) to accumulate in brain. AD progresses due to: (1) activation of a harmful positive feedback loop that progressively worsens the effects of insulin resistance; and (2) the formation of ROS- and RNS-related lipid, protein, and DNA adducts that permanently damage basic cellular and molecular functions. Epidemiologic data suggest that insulin resistance diseases, including AD, are exposure-related in etiology. Furthermore, experimental and lifestyle trend data suggest chronic low-level nitrosamine exposures are responsible. These concepts offer opportunities to discover and implement new treatments and devise preventive measures to conquer the AD and other insulin resistance disease epidemics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,876
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 7×
“These and other consequences help drive pro-apoptosis, pro-inflammatory, and pro-AβPP-Aβ cascades, which worsen DNA damage, mitochondrial dysfunction, oxidative stress, and ROS generation [3, 8, 18, 19, 28].”
BackgroundInfluentialMetabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171 · cited 1×
“In humans, weight loss sufficient to reduce peripheral insulin resistance improves cognitive performance [122, 123] and enhances neuropsychiatric function [124], and reductions in metabolic indices through Mediterranean diet adherence lowers the risk for AD [125].”
BackgroundAlzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · cited 1×
“Obesity is linked to insulin resistance and substantially increases risk for T2DM, NAFLD, NASH, metabolic syndrome, and cognitive impairment [111-114].”
BackgroundClassification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Radicals and oxidative stress in diabetes
West, I. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00259.x · Cited by 913
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Insulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · cited 7×
“These and other consequences help drive pro-apoptosis, pro-inflammatory, and pro-AβPP-Aβ cascades, which worsen DNA damage, mitochondrial dysfunction, oxidative stress, and ROS generation [3, 8, 18, 19, 28].”
BackgroundInfluentialElevated body mass index is associated with executive dysfunction in otherwise healthy adults
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B., & Gordon, E. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.05.001 · Cited by 668
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Role for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 637
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Mosconi, L., Pupi, A., & De Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 595
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Relation of diabetes to mild cognitive impairment
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.570 · Cited by 592
de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7106 · Cited by 553
Self-citationBhat, R., Xue, Y., Berg, S., Hellberg, S., Ormö, M., Nilsson, Y., Radesäter, A.-C., Jerning, E., Markgren, P.-O., Borgegård, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306268200 · Cited by 552
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
Lannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.5.1199 · Cited by 525
Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487 · cited 1×
“With regard to the brain, epidemiological and clinical studies showed that glucose intolerance, deficits in insulin secretion, and insulin resistance diseases (T2DM, obesity/dyslipidemic disorders, or NASH) all increase risk for developing mild cognitive impairment (MCI) or AD-type dementia [8, 115-117].”
BackgroundPathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
Self-citationFree fatty acids and insulin resistance
Delarue, J., & Magnan, C. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328042ba90 · Cited by 466
Oxidative stress in Alzheimer disease
Gella, A., & Durany, N. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7402 · Cited by 459
The Korsakoff Syndrome: Clinical Aspects, Psychology and Treatment
Kopelman, M. D., Thomson, A. D., Guerrini, I., & Marshall, E. J. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn118 · Cited by 458
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
M. de la Monte, S. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 448
Impact of Metabolic Syndrome on Cognition and Brain: A Selected Review of the Literature
Yates, K. F., Sweat, V., Yau, P. L., Turchiano, M. M., & Convit, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.252759 · Cited by 444
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 434
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433 · cited 1×
“Neuro- inflammation contributes to AD pathology by promoting AβPP-Aβ accumulation [62], Tau hyper-phosphorylation [64], oxidative injury [65], and impairments in neuronal plasticity [66].”
BackgroundBody Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Whitmer, R., Gunderson, E., Quesenberry, C., Zhou, J., & Yaffe, K. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362047 · Cited by 430
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · cited 1×
“Chronic inflammation is mediated by activation of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) [67, 190, 191].”
BackgroundAltered Lipid Metabolism in Brain Injury and Disorders
Adibhatla, R. M., & Hatcher, J. F. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 401
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
Mandelkow, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 401
Genotoxicity of Streptozotocin
Bolzán, A. D., & Bianchi, M. S. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00044-3 · Cited by 400
Martins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
Grünblatt, E., Salkovic‐Petrisic, M., Osmanovic, J., Riederer, P., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 374
SWANN, P. F., & MAGEE, P. N. (1968) · Biochemical Journal · doi:10.1042/bj1100039 · Cited by 371
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Wei, Y., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.193 · Cited by 369
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Obesity, Inflammation, and Insulin Resistance – A Mini-Review
Zeyda, M., & Stulnig, T. M. (2009) · Gerontology · doi:10.1159/000212758 · Cited by 366
Cataldo, J. K., Prochaska, J. J., & Glantz, S. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1240 · Cited by 335
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.185 · Cited by 332
Ceramide synthesis and metabolism as a target for cancer therapy
Reynolds, C. P., Maurer, B. J., & Kolesnick, R. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.034 · Cited by 328
de la Monte, S. M., Tong, M., Lester-Coll, N., Plater, Jr., & Wands, J. R. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10113 · Cited by 325
Self-citationKolak, M., Westerbacka, J., Velagapudi, V. R., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A.-M., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 317
Does insulin dysfunction play a role in Alzheimer's disease?
Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314
Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A
Chalfant, C. E., Kishikawa, K., Mumby, M. C., Kamibayashi, C., Bielawska, A., & Hannun, Y. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20313 · Cited by 300
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Cholerton, B. A., Plymate, S. R., Fishel, M. A., Watson, G. S., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100768 · Cited by 293
Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor
Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., van Bronswijk, W., & Martins, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0001.2002 · Cited by 291
Bosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01318.x · Cited by 283
Oxidative Stress in Diabetes and Alzheimer's Disease
Reddy, V. P., Zhu, X., Perry, G., & Smith, M. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1013 · Cited by 280
Role of mitochondria in non‐alcoholic fatty liver disease
Pessayre, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04640.x · Cited by 279
Diabetes mellitus and dementia
Pasquier, F., Boulogne, A., Leys, D., & Fontaine, P. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70298-7 · Cited by 276
The ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264
Insulin increases CSF Aβ42 levels in normal older adults
Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 264
Studies of streptozotocin-induced insulitis and diabetes.
Rossini, A. A., Like, A. A., Chick, W. L., Appel, M. C., & Cahill, G. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.6.2485 · Cited by 263
Salcedo, I., Tweedie, D., Li, Y., & Greig, N. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01971.x · Cited by 259
Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease
Eikelenboom, P., van Exel, E., Hoozemans, J. J. M., Veerhuis, R., Rozemuller, A. J. M., & van Gool, W. A. (2010) · Neurodegenerative Diseases · doi:10.1159/000283480 · Cited by 259
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J.-H., Kwon, C. H., Lee, K.-W., Lee, J.-H., Park, C. K., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 257
Visceral fat is associated with lower brain volume in healthy middle‐aged adults
Debette, S., Beiser, A., Hoffmann, U., DeCarli, C., O'Donnell, C. J., Massaro, J. M., Au, R., Himali, J. J., Wolf, P. A., Fox, C. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22062 · Cited by 253
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s39-s46 · Cited by 249
Tong, M., Neusner, A., Longato, L., Lawton, M., Wands, J. R., & de la Monte, S. M. (2009) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2009-1115 · Cited by 249
Self-citationStudies of the effects of high fat diets on cognitive function in a rat model
Winocur, G., & Greenwood, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.003 · Cited by 243
Mediterranean Diet, Inflammatory and Metabolic Biomarkers, and Risk of Alzheimer's Disease
Gu, Y., Luchsinger, J. A., Stern, Y., & Scarmeas, N. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100897 · Cited by 241
Katsel, P., Li, C., & Haroutunian, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9297-x · Cited by 241
Obesity, diabetes mellitus, and liver fibrosis
Chiang, D. J., Pritchard, M. T., & Nagy, L. E. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00426.2010 · Cited by 236
Chavez, J. A., Holland, W. L., Bär, J., Sandhoff, K., & Summers, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412769200 · Cited by 219
Early-Onset Familial Alzheimer's Disease (EOFAD)
Wu, L., Rosa-Neto, P., Hsiung, G.-Y. R., Sadovnick, A. D., Masellis, M., Black, S. E., Jia, J., & Gauthier, S. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013949 · Cited by 219
Expanding the Mind: Insulin-Like Growth Factor I and Brain Development
Joseph D'Ercole, A., & Ye, P. (2008) · Endocrinology · doi:10.1210/en.2008-0920 · Cited by 209
Free fatty acids and skeletal muscle insulin resistance
Kraegen, E. W., & Cooney, G. J. (2008) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000319118.44995.9a · Cited by 206
Felipo, V., Urios, A., Montesinos, E., Molina, I., Garcia-Torres, M. L., Civera, M., Del Olmo, J. A., Ortega, J., Martinez-Valls, J., Serra, M. A., et al. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-011-9269-3 · Cited by 201
Type 2 diabetes and risk of cognitive impairment and dementia
Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 197
Hoyer, S., Nitsch, R., & Oesterreich, K. (1991) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02251132 · Cited by 196
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study
Agnoli, C., Berrino, F., Abagnato, C. A., Muti, P., Panico, S., Crosignani, P., & Krogh, V. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.006 · Cited by 195
Zeger, M., Popken, G., Zhang, J., Xuan, S., Lu, Q. R., Schwab, M. H., Nave, K., Rowitch, D., D'Ercole, A. J., & Ye, P. (2007) · Glia · doi:10.1002/glia.20469 · Cited by 192
Brain Aging in Very Old Men With Type 2 Diabetes
Korf, E. S. C., White, L. R., Scheltens, P., & Launer, L. J. (2006) · Diabetes Care · doi:10.2337/dc06-0243 · Cited by 191
Inflammatory cause of metabolic syndrome via brain stress and NF-κB
Cai, D., & Liu, T. (2012) · Aging · doi:10.18632/aging.100431 · Cited by 189
Neuroinflammatory perspectives on the two faces of Alzheimer?s disease
Eikelenboom, P., & van Gool, W. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0055-1 · Cited by 182
Human cerebral neuropathology of Type 2 diabetes mellitus
Nelson, P. T., Smith, C. D., Abner, E. A., Schmitt, F. A., Scheff, S. W., Davis, G. J., Keller, J. N., Jicha, G. A., Davis, D., Wang-Xia, W., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.005 · Cited by 181
Intramuscular lipid metabolism, insulin action, and obesity
Consitt, L. A., Bell, J. A., & Houmard, J. A. (2009) · IUBMB Life · doi:10.1002/iub.142 · Cited by 180
Eckardt, K., Taube, A., & Eckel, J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9168-2 · Cited by 178
Obesity, Metabolic Syndrome, and Type 2 Diabetes: Inflammatory Basis of Glucose Metabolic Disorders
Pradhan, A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00354.x · Cited by 175
Hoyer, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 174
Evidence of executive dysfunction in extremely obese adolescents: a pilot study
Lokken, K., Boeka, A. G., Austin, H. M., Gunstad, J., & Harmon, C. M. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.05.008 · Cited by 173
de la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 167
Self-citationMessier, C., & Teutenberg, K. (2005) · Neural Plasticity · doi:10.1155/np.2005.311 · Cited by 167
Neuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease
Morales, I., Farías, G., & Maccioni, R. B. (2010) · Neuroimmunomodulation · doi:10.1159/000258724 · Cited by 162
Clinical aspects of inflammation in Alzheimer's disease
Rosenberg, P. B. (2005) · International Review of Psychiatry · doi:10.1080/02646830500382037 · Cited by 158
Dankner, R. S., Chetrit, A., Shanik, M. H., Raz, I., & Roth, J. (2009) · Diabetes Care · doi:10.2337/dc09-0153 · Cited by 158
Lyn‐Cook, L. E., Lawton, M., Tong, M., Silbermann, E., Longato, L., Jiao, P., Mark, P., Wands, J. R., Xu, H., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0984 · Cited by 157
Self-citationEndoplasmic Reticulum Stress and Liver Injury
Kaplowitz, N., Than, T. A., Shinohara, M., & Ji, C. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-991513 · Cited by 154
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus
Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151 · cited 2×
“Correspondingly, experimental diet-induced obesity and T2DM cause cognitive declines [35] with deficits in spatial learning and memory [120], and brain atrophy with insulin resistance, inflammation, oxidative stress, and cholinergic dysfunction [111, 121].”
BackgroundDuelli, R., Schröck, H., Kuschinsky, W., & Hoyer, S. (1994) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)90053-1 · Cited by 150
Cognitive Dysfunction in Chronic Hepatitis C: A Review
Perry, W., Hilsabeck, R. C., & Hassanein, T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9896-z · Cited by 149
Marchesini, G., & Marzocchi, R. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.013 · Cited by 148
Tan, Z. S., Beiser, A., Fox, C. S., Au, R., Himali, J. J., Debette, S., DeCarli, C. S., Vasan, R. S., Wolf, P. A., & Seshadri, S. S. (2011) · Diabetes Care · doi:10.2337/dc11-0308 · Cited by 147
Hoyer, S., & Nitsch, R. M. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258634 · Cited by 146
Devaraj, S., Tobias, P. S., Kasinath, B. S., Ramsamooj, R., Afify, A. M., & Jialal, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228924 · Cited by 146
Obesity, Metabolic Syndrome, and Type 2 Diabetes: Inflammatory Basis of Glucose Metabolic Disorders
Pradhan, A. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s152-s156 · Cited by 145
The Liver-Brain Axis of Alcohol-Mediated Neurodegeneration: Role of Toxic Lipids
de la Monte, S. M., Longato, L., Tong, M., DeNucci, S. M., & Wands, J. R. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6072055 · Cited by 144
Self-citationFreude, S., Schilbach, K., & Schubert, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486527 · Cited by 144
Sphingolipids and insulin resistance: the five Ws
Summers, S. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283373b66 · Cited by 136
Insulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 134
Depression, Anxiety, and Nonalcoholic Steatohepatitis
Elwing, J. E., Lustman, P. J., Wang, H. L., & Clouse, R. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221276.17823.df · Cited by 133
The Clinical and Biological Relationship between Type II Diabetes Mellitus and Alzheimers Disease
Nicolls, M. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480555 · Cited by 131
Update on non-alcoholic fatty liver disease in children
Papandreou, D., Rousso, I., & Mavromichalis, I. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.02.002 · Cited by 131
Glycosphingolipids and insulin resistance
Langeveld, M., & Aerts, J. M. F. G. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.03.002 · Cited by 127
Krautwald, M., & Münch, G. W. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.001 · Cited by 125
Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin
Murata, M., Takahashi, A., Saito, I., & Kawanishi, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00370-0 · Cited by 125
Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum
Kaplowitz, N., & Ji, C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04581.x · Cited by 125
Chen, G., Xu, X. J., Lahousse, S. A., Caggiano, N. L., & de la Monte, S. M. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5305 · Cited by 123
de la Monte, S. M., Neusner, A. D., Chu, J., & Lawton, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1070 · Cited by 119
Non-Steroidal Anti-Inflammatory Drugs and Alzheimers Disease: The Epidemiological Evidence
Szekely, C. A., & Zandi, P. P. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012026 · Cited by 116
Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions
de la Monte, S. M., Tong, M., Nguyen, V., Setshedi, M., Longato, L., & Wands, J. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091726 · Cited by 114
Self-citationIt May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease
Arnaud, L. T., Robakis, N. K. R. K., & Figueiredo‐Pereira, M. E. (2006) · Neurodegenerative Diseases · doi:10.1159/000095638 · Cited by 114
Regulation and functions of sphingosine kinases in the brain
Bryan, L., Kordula, T., Spiegel, S., & Milstien, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.04.008 · Cited by 111
Brewer, G. J. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.11.007 · Cited by 110
Metabolic Syndrome and Cognitive Decline
Yaffe, K. S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362191 · Cited by 109
Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)
Hoyer, S., Lannert, H., Nöldner, M., & Chatterjee, S. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050232 · Cited by 109
de la Monte, S. M., & Tong, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1098 · Cited by 108
Self-citationBryan, J., & Tiggemann, M. (2001) · Appetite · doi:10.1006/appe.2000.0389 · Cited by 107
Caselli, R. J., Chen, K., Lee, W., Alexander, G. E., & Reiman, E. M. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.1 · Cited by 106
Weinstock, M., & Shoham, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0058-y · Cited by 105
Desensitization of brain insulin receptor Effect on glucose/energy and related metabolism
Hoyer, S., Müller, D., & Plaschke, K. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_20 · Cited by 104
de la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 104
Schmidt, K. S., Gallo, J. L., Ferri, C. V., Giovannetti, T., Sestito, N., Libon, D. J., & Schmidt, P. S. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000088306 · Cited by 104
Methylglyoxal, Cognitive Function and Cerebral Atrophy in Older People
Srikanth, V. K., Westcott, B., Forbes, J. M., Phan, T. G., Beare, R. J., Venn, A., Pearson, S., Greenaway, T. M., Parameswaran, V., & Münch, G. W. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls100 · Cited by 104
Cong, W.-N., Tao, R., Tian, J., Liu, G.-T., & Ye, F. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.022 · Cited by 103
The impact of dietary energy intake on cognitive aging
Mattson, M. P. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.005.2010 · Cited by 103
Gopalsamy, R. G., Stalin, A., Balakrishna, K., Savarimuthu Ignacimuthu, S. J., Paulraj, M. G., & Vishal, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.016 · Cited by 102
Evaluation and management of obesity-related nonalcoholic fatty liver disease
Nugent, C., & Younossi, Z. M. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0879 · Cited by 101
Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.30 · Cited by 100
IGF-I and the aging mammalian brain
Piriz, J., Muller, A. P., Trejo, J. L., & Torres‐Alemán, I. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.022 · Cited by 96
Metabolic diseases and cancer risk
Faulds, M. H., & Dahlman‐Wright, K. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834e0582 · Cited by 95
Insulin resistance in the brain: An old-age or new-age problem?
Williamson, R., McNeilly, A. D., & Sutherland, C. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.05.007 · Cited by 94
Is Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?
Frisardi, V., Solfrizzi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Seripa, D., Pilotto, A., & Panza, F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100015 · Cited by 93
Type 2 diabetes, related conditions, in relation and dementia: An opportunity for prevention?
Luchsinger, J. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091687 · Cited by 91
de la Monte, S. M., Tong, M., Lawton, M., & Longato, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-54 · Cited by 91
Self-citationDeochand, M. T. C. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000128 · Cited by 90
Kincaid‐Smith, P. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00001 · Cited by 89
The Effect of Low Versus High Dose of Streptozotocin in Cynomolgus Monkeys (Macaca Fascilularis)
Koulmanda, M., Qipo, A., Chebrolu, A., O'Neil, A., Auchincloss, H., & Smith, R. N. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00040.x · Cited by 89
Schisano, B., Harte, A. L., Lois, K. B., Saravanan, P., Al‐Daghri, N. M., Al-Attas, O. S., Knudsen, L. B., McTernan, P. G., Ceriello, A., & Tripathi, G. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.11.008 · Cited by 89
Alessenko, A. V., Бугрова, А. Е., & Дудник, Л. Б. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320144 · Cited by 88
Mechanisms of Ceramide-Mediated Neurodegeneration
Tong, M., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0983 · Cited by 86
Self-citationTsukamoto, E., Hashimoto, Y., Kanekura, K., Niikura, T., Aiso, S., & Nishimoto, I. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10703 · Cited by 86
Endoplasmic reticulum (ER) stress & diabetes.
Rajan, S. S., Srinivasan, V., Balasubramanyam, M., & Tatu, U. S. (2007) · PubMed · Cited by 86
de la Monte, S. M., Re, E. B., Longato, L., & Tong, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111728 · Cited by 85
Self-citationGu, F., Zhu, M., Shi, J., Hu, Y., & Zhao, Z. Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.050 · Cited by 85
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83 · cited 2×
“Insulin resistance, inflammation, and ceramide accumulation promote oxidative and ER stress, which impair mitochondrial function, energy balance, and membrane integrity, and worsen insulin resistance, inflammation, and ceramide generation [82, 83, 195-198].”
BackgroundMechanisms of AD neurodegeneration may be independent of Aβ and its derivatives
Robakis, N. K. R. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.022 · Cited by 83
Labak, M., Foniok, T., Kirk, D., Rushforth, D., Tomanek, B., Jasiński, A., & Grieb, P. (2010) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-98811-4_32 · Cited by 79
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
ETIENNE, D., Kraft, J., Ganju, N., Gómez‐Isla, T., Gemelli, B., Hyman, B. T., Hedley‐Whyte, E. T., Wands, J. R., & de la Monte, S. M. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1205 · Cited by 76
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
Burns, J. M., Honea, R. A., Vidoni, E. D., Hutfles, L. J., Brooks, W. M., & Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.011 · Cited by 74
Luque, R. M., Lin, Q., Córdoba-Chacón, J., Subbaiah, P. V., Buch, T., Waisman, A., Vankelecom, H., & Kineman, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015767 · Cited by 73
Metabolic Syndrome Is Associated with Learning and Recall Impairment in Middle Age
Hassenstab, J. J., Sweat, V., Bruehl, H., & Convit, A. J. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000296071 · Cited by 73
Tong, M., Longato, L., & de la Monte, S. M. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-4 · Cited by 73
Self-citationValentini, S., Cabreiro, F., Ackerman, D., Alam, M. M., Kunze, M. B. A., Kay, C. W. M., & Gems, D. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.03.003 · Cited by 69
Arboleda, G., Huang, J. T.-J., Waters, C. M., Verkhratsky, A., Fernyhough, P., & Gibson, R. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05557.x · Cited by 69
Sato, N., Takeda, S., Uchio‐Yamada, K., Ueda, H., Fujisawa, T., Rakugi, H., & Morishita, R. (2011) · Current Aging Science · doi:10.2174/1874609811104020118 · Cited by 67
Cai, Z., Zhao, Y., Yao, S., & Zhao, B. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70504-7 · Cited by 66
Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease
de la Monte, S. M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e482 · Cited by 64
Rahmadi, A., Steiner, N., & Münch, G. W. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.079 · Cited by 63
Oxenkrug, G. F. (2011) · Europe PMC (PubMed Central) · Cited by 62
Greilberger, J., Fuchs, D., Leblhuber, F., Greilberger, M., Wintersteiger, R., & Tafeit, E. (2010) · PubMed · Cited by 59
Olson, L., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.011 · Cited by 59
de la Monte, S. M., Tong, M., Bowling, N., & Moskal, P. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-13 · Cited by 57
Self-citationWang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
de la Monte, S. M., Chen, G., Rivera, E. J., & Wands, J. R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3305-3 · Cited by 52
Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats
Castilla‐Cortázar, I., Garcia‐Fernandez, M. I., Delgado, G., Puche, J. E., Sierra, I., Barhoum, R., & González-Barón, S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-103 · Cited by 51
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
Suzanne, M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/482 · Cited by 50
Inflammation in Neurodegenerative Disorders: Friend or Foe?
Galimberti, D., Fenoglio, C., & Scarpini, E. A. (2008) · Current Aging Science · doi:10.2174/1874609810801010030 · Cited by 48
Age-associated development of inflammation in Wistar rats: Effects of caloric restriction
Horrillo, D., Sierra, J., Arribas, C., García-San Frutos, M., Carrascosa, J. M., Lauzurica, N., Fernández-Agulló, T., & Ros, M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.577435 · Cited by 45
Kao, Y.-H., Youson, J. H., Holmes, J. A., & Sheridan, M. A. (1998) · General and Comparative Endocrinology · doi:10.1006/gcen.1998.7107 · Cited by 45
Schuh, A. F. S., Rieder, C. R. D. M., Rizzi, L., Chaves, M. L. F., & Roriz‐Cruz, M. (2011) · ISRN Neurology · doi:10.5402/2011/306905 · Cited by 35
Evolving trends in nonalcoholic fatty liver disease
Delgado, J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.02.034 · Cited by 32
Garcia, R. G., Rincón, M. Y., Arenas, W. D., Silva, S. Y., Reyes, L. M., Ruiz, S. L., Ramírez, F., Camacho, P. A., Luengas, C., Saaibi, J. F., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.10.030 · Cited by 32
Presenilin function: connections to Alzheimer's disease and signal transduction
Fraser, P. E., Yu, G., Lévesque, L., Nishimura, M., Yang, D.-S., Mount, H. T. J., Westaway, D. A., & George‐Hyslop, P. S. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670089 · Cited by 31
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV
Weiss, J. J., & Gorman, J. M. (2006) · Current HIV/AIDS Reports · doi:10.1007/s11904-006-0013-2 · Cited by 31
Dimethylnitrosamine (DMN)-induced IL-1β, TNF-α, and IL-6 inflammatory cytokine expression
Schook, L. B., Lockwood, J. F., Yang, S.-D., & Myers, M. J. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90151-h · Cited by 30
Inhibiting the formation of classical C3-convertase on the Alzheimer's β-amyloid peptide
Emmerling, M. R., Spiegel, M. K., & Watson, D. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00067-2 · Cited by 28
Colonna, S. V., Case, L. D., & Lawrence, J. A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1790-x · Cited by 27
Moreno, P., Nuche‐Berenguer, B., Gutiérrez-Rojas, I., Acitores, A., Sancho, V., Valverde, I., González, N., & Villanueva‐Peñacarrillo, M. L. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0127 · Cited by 27
Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort
Blasko, I., Jungwirth, S., Jellinger, K. A., Kemmler, G., Krampla, W. W., Weissgram, S., Wichart, I., Tragl, K. H., Hinterhuber, H., & Fischer, P. A. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.10.010 · Cited by 25
IGF-I Signaling and Effects on Longevity
Holzenberger, M. (2011) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000325914 · Cited by 18
Insulin Resistance Contributes to Obesity-Related Proteinuria
Matsumoto, H., Nakao, T., OKADA, T., Nagaoka, Y., Iwasawa, H., Tomaru, R., & Wada, T. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.548 · Cited by 17
[Drug development for tauopathy and Alzheimer's disease].
Takashima, A. (2010) · PubMed · Cited by 16
Kasai, T., Miyauchi, K., Kajimoto, K., Kubota, N., Dohi, T., Kurata, T., Amano, A., & Daida, H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832961cf · Cited by 15
Iwai, S., Murai, T., Makino, S., Min, W., Morimura, K., Mori, S., Hagihara, A., Seki, S., & Fukushima, S. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.02.008 · Cited by 15
Cited by
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Hampel, H., O’Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R., & Blennow, K. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0079-7 · Cited by 716
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Melatonin and inflammation-Story of a double-edged blade
Hardeland, R. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12525 · Cited by 455
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Metadata
- Authors
- de la Monte, S. M., & Tong, M.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 88
- Issue
- 4
- Pages
- 548-559
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2005441052
- Cited by
- 461
- References
- 202
- FWCI
- 28.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.